The ratings of 6 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Merck & Co., Inc. (MRK) gets weaker ratings this week as last week’s C drops to a D. Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company also gets F’s in earnings growth and earnings momentum. For more information, get Portfolio Grader’s complete analysis of MRK stock.
This week, Amphastar Pharmaceuticals, Inc.’s (AMPH) rating worsens to a D from the company’s C rating a week ago. The company also gets F’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of AMPH stock.
Slipping from a C to a D rating, Alcobra Ltd. (ADHD) takes a hit this week. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of ADHD stock.
Parnell Pharmaceuticals Holdings Ltd. (PARN) earns a D this week, moving down from last week’s grade of C. The company also gets F’s in return on equity. For more information, get Portfolio Grader’s complete analysis of PARN stock.
Intellipharmaceutics International Inc. (IPCI) experiences a ratings drop this week, going from last week’s C to a D. Intellipharmaceutics International Inc. develops drug delivery technologies. The company also gets F’s in sales growth, earnings revisions, and free cash flow. For more information, get Portfolio Grader’s complete analysis of IPCI stock.
DURECT Corporation (DRRX) slips from a C to a D this week. DURECT Corporation is a specialty pharmaceutical company that develops pharmaceutical systems technologies based on its proprietary drug delivery technology platforms. The company also gets F’s in return on equity. For more information, get Portfolio Grader’s complete analysis of DRRX stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
